Bibliografia Biotrue® a 360°: dalla lente al sostituto lacrimale, il supporto quotidiano per gli occhi
- ACLM online: www.aclm.org.uk/online-access. 2024.
2. Bergmanson J., Clinical Ocular Anatomy and Physiology. 14th ed. 2007. - Bausch + Lomb; 2012. Twenty-two subjects participated in a randomized, double-masked, contralateral eye study to evaluate water loss of Biotrue® ONEday and 1-Day ACUVUE Moist contact lenses. After 4, 8, 12, and 16 hours of wear, lenses were removed and immediately weighed (wet weight). The lenses were then completely dried and reweighed (dry weight). The percent water loss was then calculated for each lens from the wet and dry weights.
- Lo, Tomy, Chan, Osbert, Reindel, Bill, Steffen, Non Invasive Tear Break Up Time Evaluation of Six Unique Daily Disposable Lens Materials After 10 Hours of Wear. Global Specialty Lens Symposium. January 2020. A study to evaluate the non-invasive tear break up time of 6 unique daily disposable lens materials after 10 hours of wear (delefilcon A, etafilcon A, nelfilcon A, nesofilcon A, senofilcon A and somofilcon A).
- Bausch + Lomb, 2012. Bausch + Lomb nesofilcon A contact lens (#510(k) Summary). ochester, NY.
- Lee, Rosa. Design Intent of Spherical Aberration Control Using Nesofilcon A Family of Lenses. Bausch + Lomb 2013.
- Assessment of Patient Satisfaction After a Fitting with: Bausch + Lomb Biotrue® ONEday. Italy. Gallileo Consulting. Dec 2021.
- Bausch + Lomb, 2016. A study to evaluate product performance of two designs of soft toric lenses. Rochester, NY.
- Bausch and Lomb, 2016. Biotrue® ONEday for Astigmatism (nesofilcon A Toric) Design Description. Rochester, NY.
- Bausch + Lomb. 2013. A Study to Evaluate a Mid Add Multi-Focal Soft Contact Lens Clinical Summary Report. Rochester, NY.
- Bausch + Lomb Biotrue® ONE day for Presbyopia Fitting Guide.
- Optical Design and Power Profiles for Biotrue® ONEday for Presbyopia, Rochester NY, 2013.
- Strategic Pharma Surveys; Statistical Analysis of Biotrue® ONEday For Presbyopia Patient Survey.
- Acreman, T, Jack, A, Easton, J. Study #567. Feb 2009. Millward Brown Healthcare.
- Blotrue® MPS 2018 IHUT Final Report. Valeant Pharmaceuticals North America
- Menzel, T; Mosehauer, G; Rah, M; Troast, Jennifer. 2016 Disinfection Efficacy of Biotrue® MPS and Competitor Multi-Purpose Solutions.
- Moses, R.A., Hart, W.M., Adlers: Physiology of the eye. Clinical Application. 1987
- Burke, S.E., Fridman, K.M., Scheuer, C.A., Barniak, V.L. Physical properties of multipurpose contact lens care solutions. Rochester, NY. 2010.
- C.A. Scheuer et al., Retention of conditioning agent hyaluronan on hydroget contact Lenses. Rochester, NY. 2010
- Barniak V.L., Burke S.E., Vernkatesh S. Contact Lens & Anterior Eye publication: “Comparative evaluation of multi-purpose solutions in the stabilization of tear lysozyme”. Rochester, NY. 2010.
- M. Jones, A. YaYa, D. Heiler. Protein Removal Study with Biotrue Multi-Purpose Solution. Rochester, NY. 2016.
- Frescura et al. Evaluation of Hyaluronan in Human Tears. Biochemical Society Transactions (1994) 22
- Lerner, L et al. Hyaluronan and CD44 in the Human Cornea and Limbal Conjunctiva. Exp. Eye Res. (1998) 67, 481+484 Article Number: ey980567.
- Callahan, D. 2008. ISO/FDA Stand Alone Procedure for Disinfecting Products (FDA Modification) of BL-3100-BPZO2 Multipurpose Solution (Lots SDJ023-2, SDJO24-2, SDJ027) at the Initial Stability Time Point Using Organic Soil. Bausch & Lomb Laboratory Report.
- Biotrue® Soluzione oftalmica IFU, 2024
- Biotrue® Advance IFU, 2024
- Biotrue® Gel oculare IFU, 2023
Materiale ad uso esclusivo dei Sigg. Ottici. Biotrue® sferica, Biotrue® for astigmatism, Biotrue® for Presbyopia, Biotrue® MPS, Biotrue® soluzione oftalmica, Biotrue® Advance, Biotrue® Gel Oculare sono dispositivi medici CE0050 e CE0483. Biotrue® è marchio registrato di Bausch + Lomb Inc. e sue affiliate© 2025 Bausch&Lomb Incorporated.
